REFERENCES
- Bodmeier R., Chen H. Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen. J. Control. Release 1989; 10: 167–175
- Duncan R. The dawning era of polymer therapeutics. Nat. Rev. 2003; 2: 347–360
- Edlund U., Albertsson A.-C. Degradable polymer microspheres for controlled drug delivery. Adv. Polym. Sci. 2002; 157: 67–112
- Engelberg I., Kohn J. Physico-mechanical properties of degradable polymers used in medical applications: A comparative study. Biomaterials 1991; 12: 292–303
- Flandroy P. M. J., Grandfils C., Jerome R. Clinical applications of microspheres in embolization and chemoembolization: Comprehensive review and perspectives. Pharmaceutical particulate carriers: Therapeutic applications, A. Rolland. Marcel Dekker Inc, New York 1993; 321–366
- Fu Y.-J., Shyu S.-S., Su F.-H., Yu P.-C. Development of biodegradable co-poly(D, L-lactic/glycolic acid) microspheres for the controlled release of 5-FU by the spray drying method. Colloids Surf., B 2002; 25(4)269–279
- Gopferich A. Mechanisms of polymer degradation and erosion. Biomaterials 1996; 17: 103–114
- Jain J. A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000; 21: 2475–2490
- Khandare J., Minko T. Polymer-drug conjugates: Progress in polymeric prodrugs. Prog. Polym. Sci. 2006; 31: 359–397
- Nam Y. S., Park T. G. Protein loaded biodegradable microspheres based on PLGA-protein bioconjugates. J. Microencapsulation 1999; 16(5)625–637
- Oh J. E., Nam Y. S., Lee K. H., Park T. G. Conjugation of drug to poly(D, L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres. J. Control. Release 1999; 57: 269–280
- Park T. G. Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition. Biomaterials 1995; 16: 1123–1130
- Perumal D., Dangor C. M., Alcock R. S., Hurbans N., Moopanar K. R. Effect of formulation variables on in vitro drug release and micrometric properties of modified release ibuprofen microspheres. J. Microencapsulation 1999; 16: 475–487
- Rimoli M. G., Avallone L., de Caprariis P., Galeone A., Forni F., Vandelli M. A. Synthesis and characterisation of poly(D, L-lactic acid)-idoxuridine conjugate. J. Control. Release 1999; 58: 61–68
- Thompson C. J., Hansford D., Higgins S., Hutcheon G. A., Rostron C., Munday D. L. Enzymatic synthesis and evaluation of new novel ω–pentadecalactone polymers for the production of biodegradable microspheres. J. Microencapsulation 2006; 23(2)213–226
- Thompson C. J., Hansford D., Higgins S., Rostron C., Hutcheon G. A., Munday D. L. Evaluation of ibuprofen-loaded microspheres prepared from novel copolyesters. Int. J. Pharm. 2007; 329: 53–61
- Tice T. R., Cowsar D. R. Biodegradable controlled-release parenteral systems. Pharm. Technol. 1984; 11: 26–36
- Ustariz-Peyret C., Coudane J., Vert M., Kaltsatos V., Boisrame B. Labile conjugation of a hydrophilic drug to PLA oligomers to modify a drug delivery system: Cephradin in a PLAGA matrix. J. Microencapsulation 2000; 17(5)615–624
- Yoo H. S., Lee K. H., Oh J. E., Park T. G. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J. Controlled Release 2000; 68: 419–431
- Zhu K. J., Li Y., Jiang H. L., Yasuda H., Ichimaru A., Yamamoto K., Lecomte P., Jerome R. Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(ε-caprolactone) and their copolymers. J. Microencapsulation 2005; 22: 25–36